ondansetron has been researched along with Inadequate Sleep in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A | 1 |
| Muresanu, DF | 1 |
| Lafuente, JV | 1 |
| Patnaik, R | 1 |
| Tian, ZR | 1 |
| Buzoianu, AD | 1 |
| Sharma, HS | 1 |
1 other study available for ondansetron and Inadequate Sleep
| Article | Year |
|---|---|
Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron.
Topics: Animals; Blood Proteins; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Cognition Disorde | 2015 |